reference/2883138

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2883138

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	706
issn	1098-5514 0022-538X
issueIdentifier	2
pageRange	701-706
publicationName	Journal of Virology
startingPage	701
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5370c2c5604fe770bcb32946cd0c00b3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_60aa35d0ea618be5be3b6b87fa5ac1f1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_76f750fc66d348f92ad27597100ae998
bibliographicCitation	Markowitz M, Mo H, Kempf DJ, Norbeck DW, Bhat TN, Erickson JW, Ho DD. Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor. J Virol. 1995 Feb;69(2):701–6. doi: 10.1128/jvi.69.2.701-706.1995.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efceac480823438b0cd1452005d11b8e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cc19013589540ede65de22c1e5b439e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2aa5ec954b3956dc694c413ddc0b315c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f649bf00692b2ace1eb380b8a95facb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_110dd5c473f6bf0823b1a24f208325fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6dc0c6b79ac37b4e50e419986378ece http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd7800cd554cebc7dd927a3e7a9d0702
date	199502
identifier	https://pubmed.ncbi.nlm.nih.gov/7815532 https://pubmed.ncbi.nlm.nih.gov/PMC188631 https://doi.org/10.1128/jvi.69.2.701-706.1995
isPartOf	https://portal.issn.org/resource/ISSN/0022-538X https://portal.issn.org/resource/ISSN/1098-5514 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5334
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor
discusses	http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0022497 http://id.nlm.nih.gov/mesh/M0024965 http://id.nlm.nih.gov/mesh/M0026300 http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0028918
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017320Q000494 http://id.nlm.nih.gov/mesh/D000998Q000494 http://id.nlm.nih.gov/mesh/D015497Q000187 http://id.nlm.nih.gov/mesh/D013844Q000494 http://id.nlm.nih.gov/mesh/D014633Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013329 http://id.nlm.nih.gov/mesh/D003198 http://id.nlm.nih.gov/mesh/D014633Q000494 http://id.nlm.nih.gov/mesh/D000595 http://id.nlm.nih.gov/mesh/D019438 http://id.nlm.nih.gov/mesh/D008969 http://id.nlm.nih.gov/mesh/D004351 http://id.nlm.nih.gov/mesh/D016297 http://id.nlm.nih.gov/mesh/D016333Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6287 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6780

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID612199

Total number of triples: 59.